Vanguard Group’s Context Therapeutics CNTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.2M | Buy |
3,360,582
+107,115
| +3% | +$70.2K | ﹤0.01% | 3504 |
|
|
2025
Q1 | $1.99M | Sell |
3,253,467
-1,996
| -0.1% | -$1.22K | ﹤0.01% | 3491 |
|
|
2024
Q4 | $3.42M | Sell |
3,255,463
-489,498
| -13% | -$514K | ﹤0.01% | 3403 |
|
|
2024
Q3 | $7.34M | Sell |
3,744,961
-757,237
| -17% | -$1.48M | ﹤0.01% | 3108 |
|
|
2024
Q2 | $9.03M | Buy |
4,502,198
+3,903,895
| +652% | +$7.83M | ﹤0.01% | 2987 |
|
|
2024
Q1 | $826K | Buy |
598,303
+2,291
| +0.4% | +$3.16K | ﹤0.01% | 3875 |
|
|
2023
Q4 | $673K | Buy |
596,012
+2,521
| +0.4% | +$2.85K | ﹤0.01% | 3947 |
|
|
2023
Q3 | $896K | Buy |
593,491
+18,791
| +3% | +$28.4K | ﹤0.01% | 3879 |
|
|
2023
Q2 | $920K | Buy |
574,700
+1,300
| +0.2% | +$2.08K | ﹤0.01% | 3932 |
|
|
2023
Q1 | $322K | Sell |
573,400
-67,463
| -11% | -$37.9K | ﹤0.01% | 4230 |
|
|
2022
Q4 | $418K | Buy |
640,863
+164
| +0% | +$107 | ﹤0.01% | 4150 |
|
|
2022
Q3 | $711K | Buy |
640,699
+11,720
| +2% | +$13K | ﹤0.01% | 4106 |
|
|
2022
Q2 | $1.33M | Buy |
628,979
+392,700
| +166% | +$832K | ﹤0.01% | 3989 |
|
|
2022
Q1 | $513K | Buy |
236,279
+21,600
| +10% | +$46.9K | ﹤0.01% | 4392 |
|
|
2021
Q4 | $571K | Buy |
+214,679
| New | +$571K | ﹤0.01% | 4408 |
|